Optometrists in Kalamazoo, MI Accepting Medicare

48 Optometrists found. Showing 21 - 40

Dr. Gina Terese Ford, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 501 N 9th St, Kalamazoo, MI 49009 Phone: 269-544-2952

Molly S. Redmond, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1000 Oakland Dr, 4th Floor, Kalamazoo, MI 49008 Phone: 269-387-7000

Dr. Heather Prater, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 333 Turwill Lane, Kalamazoo, MI 49006 Phone: 269-373-3937

Rx Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1727 S Park St, Kalamazoo, MI 49001 Phone: 269-342-3910    Fax: 269-342-5263

Rx Optical Laboratories, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 1700 S Park St, Kalamazoo, MI 49001 Phone: 269-342-0003    Fax: 269-342-4284

Rx Optical Laboratories, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5349 W Main St, Kalamazoo, MI 49009 Phone: 269-349-7627

West Point Optical Group Optometrist Medicare: Not Enrolled in Medicare Practice Location: 575 S Drake Rd, Kalamazoo, MI 49009 Phone: 269-382-5942

Rx Optical Laboratories, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 155 W Michigan Ave Ste 1c, Kalamazoo, MI 49007 Phone: 269-342-0134    Fax: 269-342-4284

Dr. David A. Dueweke, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 124 W. South St., Kalamazoo, MI 49007 Phone: 269-381-8620    Fax: 269-342-6833

Rebecca April Johnson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7121 Standiford St, Kalamazoo, MI 49009 Phone: 989-640-4236

Michigan Nursing Home Optical Services Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5917 Stadium Dr, Kalamazoo, MI 49009 Phone: 269-353-3870    Fax: 269-353-6088

Rx Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2067 S Drake Rd, Kalamazoo, MI 49006 Phone: 269-366-3664    Fax: 269-366-3665

Dr. Erik Steven Hanson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1700 S Park St, Kalamazoo, MI 49001 Phone: 269-342-0003    Fax: 269-342-4284

Dr Adam R Risko D.o. Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4425 W Main St, Kalamazoo, MI 49006 Phone: 269-345-4425    Fax: 269-345-4435

Dr. Aaron John Whitsett, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 3013 Oakland Dr, Kalamazoo, MI 49008 Phone: 269-382-3453    Fax: 269-382-2740

Dr. Stephanie Lynn Gelfius, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2121 Hudson Ave, Suite 105, Kalamazoo, MI 49008 Phone: 269-345-2916    Fax: 269-345-5335

Alexandra Copeland, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 7161 W Q Ave, Kalamazoo, MI 49009 Phone: 269-870-7334

Dr. Susan Beth Connolly, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 4425 W Main St, Kalamazoo, MI 49006 Phone: 269-345-4425

Innovative Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 7161 W Q Ave, Kalamazoo, MI 49009 Phone: 847-738-1517

Zachery Hulet, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5349 W Main St, Kalamazoo, MI 49009 Phone: 269-349-7627

News Archive

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

A signaling protein that is key in orchestrating the body's overall immune response has an important localized role in fighting bacterial infection and inflammation in the intestinal tract, according to a study by UC San Diego School of Medicine investigators, published in the journal Cell Host and Microbe.

Drugs that target malignant cells increase life expectancy in advanced breast cancer patients

Clinical studies show that new drugs that target malignant cells of HER2-positive breast cancer, such as Pertuzumab and Trastuzumab Emtansine (T-DM1), increase life expectancy in patients with advanced breast cancer.

Different perspective on World Health Report 2000 on health systems

Martin McKee, Professor of European Health at the London School of Hygiene & Tropical Medicine has contributed one of three commentaries appearing today in the journal Health Policy and Planning, each of which take a different perspective on the World Health Report 2000 on health systems (WHR2000).

Read more Medical News

› Verified 4 days ago

• 1
• 2(current)
• 3